Core Viewpoint - The company has completed the cancellation of three fundraising special accounts and is addressing the management and utilization of its raised funds, including the impact of legal disputes on account operations [2][12][13]. Group 1: Fundraising Overview - The company was approved to issue convertible bonds amounting to 520 million yuan, with a net fundraising amount of approximately 509.2 million yuan after deducting issuance costs [3]. - The funds are managed in special accounts established with the approval of the board, ensuring compliance with relevant regulations [4]. Group 2: Fund Management and Utilization - The company has implemented a three-party supervision agreement for the management of the raised funds, ensuring that the funds are stored in dedicated accounts [4][6]. - In 2023, the company approved the use of raised funds to increase capital in its wholly-owned subsidiary, QingTian XiaoHuangYa, for the implementation of specific projects [5][8]. Group 3: Account Cancellation and Legal Issues - The company has recently completed the cancellation of three fundraising special accounts, while one account remains frozen due to a legal dispute, involving an amount of 2,753.75 yuan [2][12][13]. - The company plans to announce further details regarding the frozen account once the situation is resolved [2][13].

Group 1 - The company Guangdong Lier New Materials Technology Co., Ltd. has signed a tripartite supervision agreement for the storage of raised funds to ensure the safety and proper use of the funds raised from the issuance of shares [3][4] - The company was approved to issue 5,919,871 shares at a price of RMB 26.96 per share, raising a total of RMB 159,599,722.16, with a net amount of RMB 153,816,994.29 after deducting issuance costs [2][4] - The funds raised will be stored in a special account opened specifically for this purpose, and the company has authorized its management to handle related matters [4][6] Group 2 - The tripartite supervision agreement involves the company, the banks where the funds are stored, and the sponsor, Century Securities, to ensure compliance with relevant regulations [6][7] - The agreement stipulates that the special account can only be used for the company's fundraising projects and outlines the responsibilities of each party involved [6][8] - The sponsor has the right to supervise the use of the funds and must be notified if the company withdraws more than 20% of the net amount from the special account within 12 months [7][8]

证券代码：603376 证券简称：大明电子 公告编号：2026-001 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 一、募集资金的基本情况 经中国证券监督管理委员会《关于同意大明电子股份有限公司首次公开发行股票注册的批复》（证监许 可〔2025〕1643号）同意注册，并经上海证券交易所同意，大明电子股份有限公司（以下简称"公司"） 向社会公开发行人民币普通股（A股）4,000.10万股，发行价格为12.55元/股，本次发行募集资金总额为 502,012,550.00元，扣除发行费用78,190,571.41元（不含增值税）后，募集资金净额为423,821,978.59 元。容诚会计师事务所（特殊普通合伙）对公司本次公开发行新股的资金到位情况进行了审验并出具了 《验资报告》（容诚验字[2025]230Z0132号）。 二、募集资金管理情况 为了规范公司募集资金的存放、使用和管理，维护投资者的合法权益，确保公司募投项目顺利开展，提 高募集资金使用效率，根据《上市公司募集资金监管规则》《上海证券交易所上市公司自律监管指引第 1号 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 2020年6月30日，本公司与子公司南京安赛莱医药科技有限公司、广发银行股份有限公司扬州分行、中 国建设银行股份有限公司南京鼓楼支行和华泰联合证券签署《募集资金专户存储五方监管协议》,在广 发银行股份有限公司扬州分行开设募集资金专项账户(账号：9550880058239300203),在中国建设银行股 份有限公司南京鼓楼支行(建宁路支行)开设募集资金专项账户(账号：32050159524609999996)。 2020年6月30日，本公司与子公司扬州艾迪医药科技有限公司、江苏银行股份有限公司扬州分行和华泰 联合证券签署《募集资金专户存储四方监管协议》,在江苏银行股份有限公司扬州分行(唐城支行)开设募 集资金专项账户(账号：90160188000125327)。 2022年1月19日，公司召开第一届董事会第二十一次会议和第一届监事会第十七次会议，审议通过了 《关于变更部分募集资金专项账户及新增募集资金专项账户的议案》。 2022年1月26日，本公司与中国建设银行股份有限公司江苏省分行和华泰联合证券签署《募集资金专户 存储三方监管协议》,在中国建设银行股份有限公司 ...

Group 1 - The company has repaid a total of RMB 190 million of temporarily used idle raised funds as of January 13, 2026 [1][2][3] - The board of directors and the supervisory board approved the use of RMB 190 million of idle raised funds for temporary working capital on January 15, 2025, with a usage period not exceeding 12 months [1] - The company has returned the RMB 190 million to its special account for raised funds and notified the sponsor institution and representative in a timely manner [3]

（编辑 楚丽君） 证券日报网讯 1月13日，甘咨询在互动平台回答投资者提问时表示，公司严格按照《上市公司募集资金 监管规则》和《深圳证券交易所上市公司自律监管指引第1号——主板上市公司规范运作》等有关规定 使用暂时闲置募集资金开展现金管理，并及时履行信息披露义务。公司董事会持续关注募集资金存放、 管理和使用情况，有效防范投资风险，提高募集资金使用效益，无其他应披露而未披露的信息。 ...

Core Viewpoint - Guangkang Biochemical received a warning letter from the Guangdong Securities Regulatory Bureau due to violations related to the management and use of raised funds, specifically regarding the purchase of non-principal guaranteed financial products without adequate risk disclosure [1][2]. Group 1: Regulatory Actions - The Guangdong Securities Regulatory Bureau issued a warning letter to Guangkang Biochemical and its executives, Cai Danqun and Chen Haixia, for failing to fulfill their responsibilities under the Information Disclosure Management Measures [2]. - The company was found to have used raised funds to purchase 179 financial products, of which 158 were non-principal guaranteed, without sufficient disclosure of the associated risks in their reports [1][2]. Group 2: Financial Details - Guangkang Biochemical was listed on the Shenzhen Stock Exchange's ChiNext on June 27, 2023, issuing 18.5 million shares at a price of 42.45 yuan per share, which currently trades below its initial offering price [2]. - The total amount raised by the company was 785.325 million yuan, with a net amount of 697.3657 million yuan after deducting issuance costs, which exceeded the initially planned amount by 6.1779 million yuan [2].

Core Viewpoint - The company, Anhui Xinke New Materials Co., Ltd., is planning to issue A-shares to specific investors, aiming to raise funds for repaying bank loans and supplementing working capital, which is expected to enhance its capital structure and reduce financial costs [11][15]. Group 1: Fundraising and Financial Impact - The total amount of funds to be raised is estimated at 350 million yuan, with the issuance of approximately 109,034,267 shares [12]. - The company anticipates that the issuance will dilute immediate returns, with potential impacts on key financial metrics, including earnings per share [14]. - The company has outlined specific measures to mitigate the dilution of immediate returns, including improving operational efficiency and enhancing management practices [16][17]. Group 2: Governance and Compliance - The company has established a fundraising management system to ensure compliance with relevant laws and regulations, and to manage the raised funds effectively [4][17]. - The board of directors has been authorized to make necessary adjustments to the fundraising plan in response to changes in regulations or market conditions [3][4]. - Commitments from major shareholders and management have been made to ensure the fulfillment of measures aimed at compensating for the dilution of immediate returns [20][21]. Group 3: Shareholder Engagement and Future Strategy - The company has committed to maintaining a robust dividend policy to protect shareholder interests, particularly for minority shareholders [19]. - The board has proposed a plan for the first extraordinary general meeting of 2026 to discuss these matters further [9][10]. - The company aims to strengthen its competitive position in the market through strategic investments and operational improvements following the fundraising [15][16].

Core Viewpoint - The company has utilized its own funds to pay for part of the fundraising investment projects and will replace these amounts with raised funds, amounting to RMB 29.2643 million, in compliance with regulations regarding fund replacement within six months of payment [2][8]. Fundraising Basic Situation - The company raised a total of RMB 1,827.1 million through a non-public offering of 396,334,048 shares at a price of RMB 4.61 per share, with a net amount of RMB 1,814.1 million after deducting issuance costs [3][4]. - The funds were deposited on January 16, 2023, and are managed in a dedicated account with a tripartite supervision agreement in place [3][4]. Investment Project Situation - The company has adjusted its fundraising investment projects, extending the timeline for several projects to December 31, 2027, without changing the total investment amount or project content [4]. Use of Own Funds and Replacement - The necessity for using own funds arises from difficulties in direct payments from the fundraising account, particularly for employee salaries and social insurance, which must be processed through the company's basic deposit account [6]. - The process for replacing own funds with raised funds includes submitting payment requests, maintaining detailed records, and ensuring compliance with approval procedures [7]. Impact on the Company - The use of own funds for project payments and subsequent replacement with raised funds is expected to enhance the efficiency of fund utilization and overall operational management, benefiting the company and its shareholders [9]. Special Opinions - The sponsor institution has confirmed that the company's actions regarding the use of own funds and their replacement with raised funds have been properly approved and do not affect the normal implementation of fundraising projects [10].

Core Viewpoint - ST Pava has decided to terminate the investment project for an annual production of 15,000 tons of ternary precursor materials, citing changes in the industry and market environment as the primary reason for this decision [1][4] Group 1: Project Termination Details - The company announced the termination of the "annual production of 15,000 tons ternary precursor project" on January 9, 2026, which requires shareholder approval [1] - The project was initially part of a public offering that raised approximately 17.43 billion yuan, with a net amount of about 15.95 billion yuan after expenses [1] - The remaining funds from the terminated project will continue to be managed in a dedicated account [1] Group 2: Revised Investment Projects - The revised investment plan includes three projects: an annual production of 25,000 tons ternary precursor project (investment of 787.11 million yuan, with 701.88 million yuan used by November 30, 2025), the terminated 15,000 tons project (investment of 472.27 million yuan, with 190.94 million yuan used), and working capital supplementation (investment of 250 million yuan, with 253.13 million yuan used) [2] - The total investment for these projects is approximately 1.51 billion yuan, with 1.14 billion yuan already utilized [2] Group 3: Project Status and Financials - The annual production of 25,000 tons ternary precursor project has been completed and is operational, while the 15,000 tons project was initially planned for a 24-month construction period, now extended to August 2026 [3] - As of November 30, 2025, the terminated project has utilized 190.94 million yuan, leaving approximately 301.29 million yuan in remaining funds [3] Group 4: Rationale for Termination - The decision to terminate the project is based on significant changes in the industry and market conditions, necessitating a dynamic adjustment of business strategies and capacity planning [4] - The company faces challenges with raw material costs and market competition, which could lead to inefficiencies in fund usage if the project were to continue [4] - The termination is expected to enhance the efficiency of fund usage and optimize resource allocation, aligning with the company's future strategic goals [4]